Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash flows from operating activities
Net income (loss)	$ (74)	$ (13)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	24	17
Intangible asset amortization	80	79
Noncash lease expense	6	7
Financing fee and premium amortization	(1)	(1)
Share-based compensation expense	37	33
(Gain) loss from change in fair value of financial instruments	25	(13)
(Gain) loss from change in fair value of tax receivable agreement	8	(5)
Release of unrecognized tax provision	(1)
Deferred tax expense (benefit)	(7)
Other	1	3
Changes in operating assets and liabilities, net of business combinations:
Accounts receivable	40	(37)
Accounts payable and accrued liabilities	(117)	(82)
Other assets and liabilities	51	31
Cash provided by operating activities	72	19
Investing activities:
Capital expenditures	(45)	(41)
Cash used in investing activities	(45)	(41)
Financing activities:
Net increase (decrease) in fiduciary liabilities	(121)	327
Borrowings from banks		54
Financing fees		(3)
Repayments to banks	(6)	(60)
Principal payments on finance lease obligations	(7)	(8)
Payments on tax receivable agreements	(7)
Tax payment for shares/units withheld in lieu of taxes	(6)	(1)
Deferred and contingent consideration payments	(3)
Repurchase of shares	(10)
Other financing activities		(4)
Cash provided by (used in) financing activities	(160)	305
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(2)
Net increase (decrease) in cash, cash equivalents and restricted cash	(133)	281
Cash, cash equivalents and restricted cash at beginning of period	1,759	1,652	$ 1,652
Cash, cash equivalents and restricted cash at end of period	$ 1,626	$ 1,933	$ 1,759